KPA to adjust ideal drug classification

Published: 2004-05-18 06:56:00

Updated: 2004-05-18 06:56:00

The Insurance Committee of Korea Pharmaceutical Association (KPA) took a meeting along with chief commissioners from the city and provincial insurance related committees on May 14 to discuss and adopt an ideal readjustment of drug classification as one of the KPA's major projects this year.

In...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK